cagrilintide semaglutide combination cagrisema phase 3 results 2024 2025 Achieves 22.7% Weight Loss in REDEFINE 1 Trial CagriSema Reduces Blood Pressure in

Novo Nordisks REDEFINE 4 head-to-head trial pitting its CagriSema (GLP-1/amylin) against tirzepatide, with the aim to demonstrate superior weight loss against the most potent marketed AOM to date and establish Novo Nordisk as a player in the mid-20% weight loss league

Long-term management of the ketogenic diet: Seizure monitoring, nutrition, and supplementation

The role of gut microbiota in anxiety, depression, and other mental disorders as well as the protective effects of dietary components

As a dietary supplement, It is advised to take 1 nos of Vcap daily, preferably with meals

Resistance training is ideal for anyone who wants to lose weight, no matter your age or fitness level